Evidence map›Paper›PMID 36355019›Full record

ArticleMarine drugs2022

The Inhibitory Effect of Phycocyanin Peptide on Pulmonary Fibrosis

Run-Ze Liu, Wen-Jun Li, Juan-Juan Zhang, Zheng-Yi Liu, Ya Li, Chao Liu, Song Qin

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Molecules (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Run-Ze LiuYantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai 264003, China.
Wen-Jun LiYantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai 264003, China.
Juan-Juan ZhangYantai Jiahui Biotech Co., Ltd., Yantai 264003, China.
Zheng-Yi LiuYantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai 264003, China.
Ya LiYantai Jiahui Biotech Co., Ltd., Yantai 264003, China.
Chao LiuYantai Jiahui Biotech Co., Ltd., Yantai 264003, China.
Song QinYantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai 264003, China.ORCID 0000-0003-3151-6889
Chinese Academy of Sciences · CN

Funding

National key research and development program 2018YFD0901102National key research and development program 2021YFC2103900
6 · The paper itself

Abstract

Phycocyanin is an excellent antioxidant with anti-inflammatory effects on which recent studies are growing; however, its specific target remains unclear. Linear tetrapyrrole compounds such as bilirubin have been shown to lead to the induction of heme oxygenase 1 expression

Indexed as

Heme Oxygenase-1PhycocyaninAnti-Inflammatory AgentsAntioxidantsBilirubinFibrosisHumansInflammationKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Oxidative StressTetrapyrrolesAnti-Inflammatory AgentsAntioxidantsBilirubinHeme Oxygenase-1Kelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2PhycocyaninTetrapyrrolesheme oxygenases-1inflammatoryoxidative stressphycocyaninphycocyanin peptidepulmonary fibrosis

Identifiers

PMID36355019
PMCPMC9694904
OpenAlexW4308456917

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.